Sign inJoin waitlistJoin the waitlist

DG

Daniel Goldstein

Internal Medicine

Credentials: ·

History

Internal Medicine
2009–2012
Medical School
2005–2009

Research

First- and second-line bevacizumab in addition to chemotherapy for metastatic colorectal cancer: a United States-based cost-effectiveness analysis
Journal of Clinical Oncology · 2015 · First of 7 authors · Corresponding · 142 citations
A Phamacoeconomic Analysis of Personalized Dosing vs Fixed Dosing of Pembrolizumab in Firstline PD-L1-Positive Non-Small Cell Lung Cancer
Journal of the National Cancer Institute · 2017 · First of 8 authors · 84 citations
Metastatic Colorectal Cancer: A Systematic Review of the Value of Current Therapies
Systematic review or meta-analysis · Clinical Colorectal Cancer · 2016 · First of 5 authors · Corresponding · 68 citations

Christopher Flowers
10 papers
Bassel El-Rayes
6 papers
Tanios Bekaii-Saab
2 papers
Amelia Langston
1 paper
Anne Noonan
1 paper
CB
Catherine Bartnik
1 paper · 1 as a resident
Conor Steuer
1 paper
Daniel Ahn
1 paper · 1 as a fellow
Douglas Murphy
1 paper
Eli Neustadter
1 paper
Emmanuel Moss
1 paper · 1 as a fellow
FK
Fadlo Khuri
1 paper